Allergy and immunology, Guidance

Applied filters

Guidance (35)
- Adverse effects (1)
- Anaphylaxis (1)
- Cautions and contraindications (1)
- Excipients (8)
- Safety in Breastfeeding (20)
- Safety in Pregnancy (1)
- Service advice and planning (6)
- Temperature management (10)
  - Stability outside the fridge (10)
Medicine (34)
- Abatacept (1)
- Acitretin (2)
- Acrivastine (1)
- Adalimumab (1)
- Alemtuzumab (1)
- Alimemazine (1)
- Alitretinoin (2)
- Anakinra (1)
- Anti-D immunoglobulin (1)
- Azathioprine (1)
- Bacillus Calmette-Guerin (1)
- Bee venom (1)
- C1-esterase inhibitor (1)
- COVID-19 vaccine (7)
- Canakinumab (1)
- Cetirizine (2)
- Chlorphenamine (2)
- Ciclosporin (2)
- Cladribine (1)
- Conestat alfa (1)
- Desloratadine (2)
- Dimethyl fumarate (2)
- Etanercept (1)
- Fexofenadine (2)
- Fingolimod (2)
- Glatiramer (1)
- Grass pollen (1)
- Hydroxyzine (1)
- Icatibant (1)
- Infliximab (1)
- Interferon alfa (1)
- Isotretinoin (1)
- Lactose (1)
- Lenalidomide (1)
- Levocetirizine (2)
- Loratadine (2)
- Methotrexate (1)
- Normal immunoglobulin human (2)
- Omalizumab (1)
- Peginterferon alfa-2a (1)
- Peginterferon beta-1a (1)
- Promethazine hydrochloride (2)
- Promethazine teoclate (1)
- Propofol (1)
- Rituximab (1)
- Siltuximab (1)
- Sodium cromoglicate (1)
- Soya oil (1)
- Tacrolimus (1)
- Tetanus immunoglobulin (1)
- Tretinoin (1)
- Ustekinumab (1)
- Vedolizumab (1)
- Wasp venom (1)
Medicines planning (17)
- New Medicines (11)
  - CCG commissioned new medicines (4)
  - NHS England commissioned new medicines (7)
  - Pre-registration new medicines (UK/EU) (1)
- Patent expiries (14)
Specialty (35)
- Allergy and immunology (35)
- Cancers (6)
- Cardiovascular system disorders (1)
- Ear, nose and throat disorders (1)
- Eyes and vision (2)
- Gastrointestinal disorders (1)
- Infection and infectious diseases (2)
- Musculo-skeletal disorders (3)
- Neurological disorders (3)
- Respiratory disorders (6)
- Skin disorders (6)
- Vaccinating (2)

Understanding the characteristics of Comirnaty 30 (XBB.1.5) vaccine

20 September 2023An overview of the Comirnaty 30 (XBB.1.5) vaccine and signposts to other useful resources.

Understanding the characteristics of Comirnaty 3 (THREE) Concentrate vaccine

19 May 2023An overview of the Comirnaty 3 micrograms/dose concentrate vaccine and signposts to other useful resources.

Understanding the characteristics of Spikevax Original/Omicron BA.4-5 vaccine

4 May 2023An overview of the Spikevax Original/Omicron BA.4-5 vaccine and signposts to other useful resources

Understanding the characteristics of VidPrevtyn Beta

27 March 2023An overview of the VidPrevtyn Beta vaccine and signposts to other useful resources

Understanding the characteristics of Comirnaty Original / Omicron BA.4-5 vaccine

27 March 2023An overview of the Comirnaty Original / Omicron BA4. 4-5 vaccine and signposts to other useful resources

Understanding the characteristics of Comirnaty 10 Concentrate (for children 5-11 years) vaccine

16 August 2022An overview of the Comirnaty 10 Concentrate for Children 5 to 11 years vaccine and signposts to other useful resources

Using antihistamines during breastfeeding

27 January 2022Guidance on continuing or initiating commonly used antihistamines whilst breastfeeding. Recommendations apply to full term and healthy infants only.

Hayfever or allergic rhinitis: treatment during pregnancy

6 January 2022Signposting evidence-based information on the treatment of hayfever or allergic rhinitis in pregnancy

Managing anaphylaxis in the COVID-19 vaccination setting

29 December 2020Advice on managing anaphylaxis in the vaccination setting with specific reference to COVID-19 vaccines.

What issues should be considered in patients with peanut allergy requiring a medicine containing soya?

16 October 2020Peanut and soya belong to the same plant family, so there is concern about cross-sensitivity. This Medicines Q&A (updated April 2020) discusses the issues to…

SPS - Specialist Pharmacy Service

NHS